Free shipping on all orders over $ 500

BIBR 953

Cat. No. M1674

All AbMole products are for research use only, cannot be used for human consumption.

BIBR 953 Structure
Synonym:

Dabigatran, Pradaxa; BIBR 953ZW

Size Price Availability Quantity
Free Sample 0.5 mg  USD 0 In stock
1mg USD 40  USD40 In stock
2mg USD 60  USD60 In stock
5mg USD 80  USD80 In stock
10mg USD 140  USD140 In stock
50mg USD 460  USD460 In stock
100mg USD 720  USD720 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BIBR 953 (Dabigatran, Pradaxa) is a highly selective, reversible, and potent thrombin inhibitor and is orally available as the prodrug, dabigatran etexilate. It has shown antithrombotic efficacy in animal models of thrombosis, with a rapid onset of action and predictable pharmacodynamic response.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method Human thrombin is dose-dependently and competitively inhibited by dabigatran (Table 2). This inhibition with a Ki of 4.5 nmol/L compares well to the Ki of melagatran (11.2 nmol/L). Real-time binding kinetics using surface plasmon resonance showed a rapid and reversible binding of dabigatran to thrombin.7 The concentration of dabigatran required tom double the in vitro coagulation time (EC2) in platelet poor plasma is species dependent and varies with the type of test (Table 3).
Concentrations
Incubation time
Animal Experiment
Animal models rabbit model of venous thrombosis
Formulation saline
Dosages a single IV administration of 5, 10, 20, and 30 mg/kg
Administration i.p.
Chemical Information
Molecular Weight 471.51
Formula C25H25N7O3
CAS Number 211914-51-1
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Blech et al. Drug Metab Dispos. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.

[2] Trocóniz et al. J Clin Pharmacol. Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery.

Related Thrombopoietin/Thrombin Products
Melagatran

Melagatran is a direct and orally active inhibitor of thrombin, without interacting with any other enzymes in the coagulation cascade or fibrinolytic enzymes aside from thrombin.

Idraparinux sodium

Idraparinux sodium (SANORG 34006) is a long-acting indirect factor Xa inhibitor.

Desirudin

Desirudin is a thrombin inhibitor that inhibits thrombosis and venous stasis thrombosis.Desirudin can be used in studies related to thrombocytopenia or platelet dysfunction.

TP508

TP508 is a 23-amino acid nonproteolytic thrombin peptide that represents a portion of the receptor-binding domain of thrombin molecule.

Succinyl-(Pro58, D-Glu65)-Hirudin (56-65) (sulfated)

Succinyl-(Pro58,D-Glu65)-Hirudin (56-65) (sulfated) is a hirugen-like peptide, and has high affnity for thrombin than Hirugen, with a KD < 100 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: BIBR 953, Dabigatran, Pradaxa; BIBR 953ZW supplier, Thrombopoietin/Thrombin, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.